DDD Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
DDD Partners's ABBV Position: Q3 2026 in Review
DDD Partners reduced its AbbVie (ABBV) stake by 19% in Q3 2026, selling an estimated $211K and leaving 3,566 shares worth $933K. The position accounts for 0.05% of the portfolio, ranked #102.
DDD Partners first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. The position peaked at $23.6M in Q1 2025. 2,580 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- DDD Partners held 3,566 shares of AbbVie worth $933K as of Q3 2026.
- DDD Partners sold 822 AbbVie shares in Q3 2026, an estimated $211K.
- AbbVie made up 0.05% of DDD Partners's portfolio in Q3 2026, its #102 holding.
- DDD Partners first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
- DDD Partners's AbbVie position peaked at $23.6M in Q1 2025.
- 2,580 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on DDD Partners's 13F filing for Q3 2026, filed 2 Nov 2026.